Biodexa Pharmaceuticals PLC ADR Ratio Change

SEC Filing 6-K (0001171843-25-004878)

Biodexa Pharmaceuticals PLC announced the effective date of the ratio change for its American Depositary Receipts (ADR) from one ADR representing ten thousand ordinary shares to one ADR representing one hundred thousand ordinary shares. This change, effective as of July 31, 2025, functions similarly to a one-for-ten reverse ADR split. The exchange of new ADRs for previously-held ADRs was automatic, with the old ADRs cancelled and new ones issued by JPMorgan Chase Bank, N.A. The total number of issued ordinary shares remains unchanged at 61,952,308,922, with 619,523 ADRs outstanding post-change. The announcement also includes forward-looking statements, cautioning about potential risks and uncertainties that could affect future results.